Test Price
600 AED✅ Home Collection Available
Large Biopsy (Histopathology with Genetic Profiling) – Comprehensive Tissue Diagnosis & Genetic Biomarker Analysis in UAE | 600 AED
Executive Summary & Core Metrics
Executive Summary:
Your definitive tissue-based diagnostic and genetic susceptibility test, performed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring 99.9% diagnostic sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing. We provide hospital-grade biopsy coordination, ISO-certified cold-chain specimen transport, and comprehensive histopathological evaluation with integrated next-generation sequencing. Post-test specialist telephonic guidance included. Verify direct insurance billing via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Large biopsy histopathology provides definitive tissue diagnosis and comprehensive genetic biomarker analysis for malignancies and hereditary cancer syndromes. This advanced diagnostic examination delivers actionable insights for personalized treatment planning through integrated immunohistochemistry and genomic profiling.
| Feature | Our Large Biopsy (Genomic) | Standard Small Biopsy |
|---|---|---|
| Precision | IHC + NGS panels for 50+ genes | Limited IHC, no NGS |
| Method | LC-MS/MS validated molecular pathology | Conventional microscopy |
| Turnaround Time | 6 working days | 5–7 days |
Physician Insight & Safety Protocols
“As a DHA-licensed specialist in diagnostic radiology, I emphasize that large biopsy results must always be correlated with clinical and imaging findings for accurate staging. The comprehensive tissue sample allows for both architectural assessment and molecular profiling, enabling precise risk stratification. Patients should discuss any anticoagulant use with their referring physician prior to the procedure.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Pre-Procedure Advisory
A valid physician referral is required for biopsy scheduling. Special considerations apply for individuals who are pregnant, planning surgical intervention, or intending to travel internationally within two weeks of the procedure. Please consult your referring physician for precise preparation instructions specific to your medical history.
Safety Exclusion Criteria & ER Red Flags
Absolute Contraindications & Warning Signs
- Uncontrolled coagulopathy or active infection at the intended biopsy site.
- Known hypersensitivity to local anesthetic agents.
- Pregnancy (procedure only performed when absolutely clinically necessary and prescribed).
- Post-biopsy: Seek emergency care immediately if you experience excessive bleeding, severe escalating pain, or signs of systemic infection such as fever or chills.
Patient FAQ & Clinical Guidance
1. What is the clinical value of a large biopsy over a fine-needle aspiration?
A large biopsy provides ample tissue for both architectural histopathology assessment and comprehensive molecular testing, including next-generation sequencing for hereditary cancer mutations, which a fine-needle aspiration cannot reliably perform. This additional tissue volume enables pathologists to evaluate tumor architecture, margin status, and stromal interactions critical for staging.
2. Is the procedure painful and what aftercare is required?
The biopsy is performed under local anesthesia, ensuring minimal discomfort during tissue collection. After the procedure, keep the dressing clean and dry for 48 hours, avoid heavy lifting or strenuous activity for one week, and monitor the site for unusual redness, swelling, or discharge. Your clinician will provide specific aftercare instructions tailored to the biopsy site.
3. How do I interpret the genetic results and discuss them with my doctor?
Your report includes a clear clinical interpretation of any pathogenic or likely pathogenic variants detected. A DHA-licensed specialist from our team will conduct a telephonic session to guide you and your oncologist in creating a surveillance, preventive, or targeted treatment plan based on the molecular findings. This ensures you fully understand the implications before your next medical appointment.
UAE Regulatory & Data Privacy Adherence
Your genetic and histopathological data is processed under the strict framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is licensed by the Dubai Health Authority (DHA Facility License No. 1143) and maintains ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) for quality management in laboratory operations.
Clinical & Logistical Metadata
| Test Name | Large Biopsy (Histopathology with Genetic Profiling) |
| Price (AED) | 600 AED |
| Turnaround Time | 6 working days |
| Sample Type / Matrix | Tissue biopsy specimen (formalin-fixed, paraffin-embedded). Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Histopathology with Immunohistochemistry (IHC) and Next-Generation Sequencing (NGS) for comprehensive genetic profiling; LC-MS/MS validated molecular pathology |
| ICD-10-CM Code | Z12.9 |
| LOINC Code | 60568-3 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians